Sign in

CIK 0001130598

  • Non-accelerated filer
  • Smaller reporting company

Traws Pharma, Inc.

Sign in to watch
Ticker
TRAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-759-3680
Business address
12 PENNS TRAIL, NEWTOWN, PA, 18940
Former names
Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 26 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-02-03 Kumar Ramesh President and CEO Exercise or conversion +20,000 $6.00 $120K 296,500
2014-02-03 Kumar Ramesh President and CEO Sale −20,000 $15.07 $301K 276,500
2014-02-03 Kumar Ramesh President and CEO Exercise or conversion · Stock Option (right to buy) −20,000 50,282
2014-01-31 Kumar Ramesh President and CEO Exercise or conversion +20,000 $6.00 $120K 296,500
2014-01-31 Kumar Ramesh President and CEO Sale −20,000 $15.03 $301K 276,500
2014-01-31 Kumar Ramesh President and CEO Exercise or conversion · Stock Option (right to buy) −20,000 70,282
2014-01-30 Kumar Ramesh President and CEO Exercise or conversion +5,256 $2.67 $14K 281,756
2014-01-30 Kumar Ramesh President and CEO Exercise or conversion +14,744 $6.00 $88K 296,500
2014-01-30 Kumar Ramesh President and CEO Sale −20,000 $15.05 $301K 276,500
2014-01-30 Kumar Ramesh President and CEO Exercise or conversion · Stock Option (right to buy) −5,256 0
2014-01-30 Kumar Ramesh President and CEO Exercise or conversion · Stock Option (right to buy) −14,744 90,282
2014-01-27 Hoffman Michael B Director Purchase +25,589 $11.86 $303K 4,374,795
2014-01-27 Michael & Jane Hoffman 2013 Descendants 10% owner Purchase +25,589 $11.86 $303K 4,374,795
2014-01-24 Hoffman Michael B Director Purchase +31,706 $11.96 $379K 4,349,206
2014-01-24 Michael & Jane Hoffman 2013 Descendants 10% owner Purchase +31,706 $11.96 $379K 4,349,206
2013-12-20 Kumar Ramesh President and CEO Grant or award · Stock Option (right to purchase) +135,000 135,000
2013-12-20 BANSAL AJAY Chief Financial Officer Grant or award · Stock Option (right to purchase) +65,000 65,000
2013-12-20 MCKEARN THOMAS J President, R&D Grant or award · Stock Option (right to purchase) +72,000 72,000
2013-12-20 Altland James SVP, Finance & Corp. Develop. Grant or award · Stock Option (right to purchase) +12,000 12,000
2013-12-19 Reddy E Premkumar Director Exercise or conversion +32,036 $1.33 $43K 1,310,754

Page 22 of 23 · 449 trades